Drugs / Aurograb
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00217841 | Jan 2004 → Mar 2006 | staphylococcal infection | NeuTec Pharma | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aurograb | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00217841 ↗ |
| Route | Intravenous | “1mg/kg i.v. b.d.” NCT00217841 ↗ |